Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GUJ.TERC LAB Share Price   (GJTL)



Here is the latest stock price and chart of GUJ.TERC LAB. For more details, see the GUJ.TERC LAB company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Must See: A Powerful Investing Opportunity is Emerging this Election Year

REFRESH
Live BSE Quotes May 24, 2024 02:44:00 PM
Price (Rs)55.95 Open (Rs) 55.95 High (Rs) 55.95 Low (Rs) 55.90
% Change1.99 Volume 1,672 Value (Rs) 93,548 52-Week H/L 70.91 / 16.65
Live NSE Quotes
Not listed
Change
1 Day
1.99%
1 Month
-17.05%
3 Months
73.17%
1 Year
163.29%
5 Years (CAGR)*
50.61%
10 Years (CAGR)*
16.81%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 0.68 P/E Ratio (x) 82.37 Market Cap (Rs m) 415.17 P/BV (x) 6.20 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

GUJ.TERC LAB Share Price Today:

GUJ.TERC LAB last traded price was up 2.0% to Rs 56.0 on the BSE. The total volume of shares traded was 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index was down by 0.3%. And the benchmark S&P BSE SENSEX was at 75,518.9 (up 0.1%).

Over the last 30 days, the GUJ.TERC LAB share price is down 20.3%. And over the last one year, GUJ.TERC LAB share price is up 155.4%.

The current market capitalisation of GUJ.TERC LAB stands at Rs 415.17 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of March 2024, company promoters held 37.03% stake in GUJ.TERC LAB, with no shares having been pledged. To know more, check out the latest shareholding pattern of GUJ.TERC LAB.

Before you go, here's an alert on GUJ.TERC LAB you may want to take note of...

Upcoming Corporate Actions for GUJ.TERC LAB

DateAnnouncementEx-Date
29-May-2024Quarterly Results-
Data Source: Equitymaster, Accord Fintech

List of All Upcoming Corporate Actions



FAQs on GUJ.TERC LAB

What is the GUJ.TERC LAB share price today?

The last traded price of GUJ.TERC LAB was Rs 56.0 on the BSE, up 2.0% over the previous close.

What is the market cap of GUJ.TERC LAB?

The current market capitalisation of GUJ.TERC LAB stands at Rs 415 m.

What is the Earnings per share (EPS) of GUJ.TERC LAB?

GUJ.TERC LAB had an EPS of Rs 0.7 in the latest financial year.

What is the PE Ratio and PB Ratio of GUJ.TERC LAB?

At the current price of Rs 56.0, GUJ.TERC LAB trades at a PE ratio of 82.37 while its PB ratio stands at 6.20.

Which are the top pharmaceuticals companies in India by marketcap?

Based on marketcap, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks ranked by marketcap here.

Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.

Which are the biggest pharmaceuticals companies in India by sales?

Based on sales, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.

Which are the biggest pharmaceuticals companies in India by net profit?

Based on net profit, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.


Today's Market

Sensex Today Trades Higher | Nifty Scales 23,000 Mark | Vodafone Idea Jumps 4% Sensex Today Trades Higher | Nifty Scales 23,000 Mark | Vodafone Idea Jumps 4%(10:30 am)

Asian stocks fell on Friday, while the dollar advanced as strong US economic data bolstered the prospect of interest rates staying higher for longer.